Seeking Alpha

Fresenius Medical Care (FMS) receives a warning letter from the FDA saying that the design...

Fresenius Medical Care (FMS) receives a warning letter from the FDA saying that the design validation process for specific dialysis machines made in Utah is incomplete. However, the FDA doesn't require a product recall, and Fresenius doesn't expect the letter to affect its earnings guidance this year. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs